Selectively impaired CD8+ but not CD4+ T cell cycle arrest during priming as a consequence of dendritic cell interaction with plasmodium-infected red cells

Journal of Immunology

Volumn 175, Issue 6, 2005, Pages 3525-3533

  Pouniotis, Dodie S ^a   Proudfoot, Owen ^a   Bogdanoska, Violeta ^a,b   Scalzo, Karen ^a   Kovacevic, Svetozar ^a,c   Coppel, Ross L ^a,c   Plebanski, Magdalena ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 7;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL DIVISION; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ERYTHROCYTE; FEMALE; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MALARIA; MEROZOITE; MOUSE; NONHUMAN; PLASMODIUM; PLASMODIUM BERGHEI; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 24744460918     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.6.3525     Document Type: Article

References (45)

1. Snow, R. W., M. H. Craig, U. Deichmann, and D. le Sueur. 1999. A preliminary continental risk map for malaria mortality among African children. Parasitol Today. 15: 99-104.
2. Plebanski, M., O. Proudfoot, D. Pouniotis, R. L. Coppel, V. Apostolopoulos, and G. Flannery. 2002. Immunogenetics and the design of Plasmodium falciparum vaccines for use in malaria-endemic populations. J. Clin. Invest. 110: 295-301.
3. Aidoo, M., A. Lalvani, C. E. Allsopp, M. Plebanski, S. J. Meisner, P. Krausa, M. Browning, S. Morris-Jones, F. Gotch, D. A. Fidock, et al. 1995. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet 345: 1003-1007.
4. Aidoo, M., and V. Udhayakumar. 2000. Field studies of cytotoxic T lymphocytes in malaria infections: implications for malaria vaccine development. Parasitol Today. 16: 50-56.
5. Doolan, D. L., and S. L. Hoffman. 1997. Pre-erythrocytic-stage immune effector mechanisms in Plasmodium spp. infections. Philos. Trans. R. Soc. Lond. B Biol. Sci. 352: 1361-1367.
6. Lalvani, A., N. Hurt, M. Aidoo, P. Kibatala, M. Tanner, and A. V. Hill. 1996. Cytotoxic T lymphocytes to Plasmodium falciparum epitopes in an area of intense and perennial transmission in Tanzania. Eur. J. Immunol. 26: 773-779.
7. Plebanski, M., M. Aidoo, H. C. Whittle, and A. V. Hill. 1997. Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa. J. Immunol. 158: 2849-2855.
8. Urban, B. C., D. J. Ferguson, A. Pain, N. Willcox, M. Plebanski, J. M. Austyn, and D. J. Roberts. 1999. Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 400: 73-77.
9. Plebanski, M., S. C. Gilbert, J. Schneider, C. M. Hannan, G. Layton, T. Blanchard, M. Becker, G. Smith, G. Butcher, R. E. Sinden, and A. V. Hill. 1998. Protection from Plasmodium berghei infection by priming and boosting T cells to a single class 1-restricted epitope with recombinant carriers suitable for human use. Eur. J. Immunol. 28: 4345-4355.
10. van Spriel, A. B., K. L. Puls, M. Sofi, D. Pouniotis, H. Hochrein, Z. Orinska, K. P. Knobeloch, M. Plebanski, and M. D. Wright. 2004. A regulatory role for CD37 in T cell proliferation. J. Immunol. 172: 2953-2961.
11. Goschnick, M. W., C. G. Black, L. Kedzierski, A. A. Holder, and R. L. Coppel. 2004. Merozoite surface protein 4/5 provides protection against lethal challenge with a heterologous malaria parasite strain. Infect. Immun. 72: 5840-5849.
12. Gett, A. V., and P. D. Hodgkin. 2000. A cellular calculus for signal integration by T cells. Nat. Immunol. 1: 239-244.
13. Schmid, I., S. W. Cole, J. A. Zack, and J. V. Giorgi. 2000. Measurement of lymphocyte subset proliferation by three-color immunofluorescence and DNA flow cytometry. J. Immunol. Methods 235: 121-131.
14. Douglas, R. S., A. D. Tarshis, C. H. Pletcher, Jr., P. C. Nowell, and J. S. Moore. 1995. A simplified method for the coordinate examination of apoptosis and surface phenotype of murine lymphocytes. J. Immunol. Methods 188: 219-228.
15. Pouniotis, D. S., O. Proudfoot, V. Bogdanoska, V. Apostolopoulos, T. Fifis, and M. Plebanski. 2004. Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect. Infect. Immun. 72: 5331-5339.
16. Ocana-Morgner, C., M. M. Mota, and A. Rodriguez. 2003. Malaria blood stage suppression of liver stage immunity by dendritic cells. J. Exp. Med. 197: 143-151.
17. Flanagan, K. L., M. Plebanski, P. Akinwunmi, E. A. Lee, W. H. Reece, K. J. Robson, A. V. Hill, and M. Finder. 1999. Broadly distributed T cell reactivity, with no immunodominant loci, to the pre-erythrocytic antigen thrombospondin-related adhesive protein of Plasmodium falciparum in West Africans. Eur. J. Immunol. 29: 1943-1954.
18. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
19. Cho, E. A., M. P. Riley, A. L. Sillman, and H. Quill. 1993. Altered protein tyrosine phosphorylation in anergic Th1 cells. J. Immunol. 151: 20-28.
20. Kip1. Eur. J. Immunol. 31: 3737-3746.
21. Beverly, B., S. M. Kang, M. J. Lenardo, and R. H. Schwartz. 1992. Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int. Immunol. 4: 661-671.
22. Filion, M. C., A. J. Bradley, D. V. Devine, F. Decary, and P. Chartrand. 1995. Autoreactive T cells in healthy individuals show tolerance in vitro with characteristics similar to but distinct from clonal anergy. Eur. J. Immunol. 25: 3123-3127.
23. Guillot, C., S. Menoret, C. Guillonneau, C. Braudeau, M. G. Castro, P. Lowenstein, and I. Anegon. 2003. Active suppression of allogeneic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig. Blood 101: 3325-3333.
24. Steinbrink, K., M. Wolfl, H. Jonuleit, J. Knop, and A. H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159: 4772-4780.
25. + CTL responses in vivo. J. Immunol. 168: 2240-2246.
26. Balkhi, M. Y., V. K. Latchumanan, B. Singh, P. Sharma, and K. Natarajan. 2004. Cross-regulation of CD86 by CD80 differentially regulates T helper responses from Mycobacterium tuberculosis secretory antigen-activated dendritic cell subsets. J. Leukocyte Biol. 75: 874-883.
27. Kip1. Eur. J. Immunol. 33: 1988-1997.
28. Bruna-Romero, O., and A. Rodriguez. 2001. Dendritic cells can initiate protective immune responses against malaria. Infect. Immun. 69: 5173-5176.
29. Luyendyk, J., O. R. Olivas, L. A. Ginger, and A. C. Avery. 2002. Antigen- presenting cell function during Plasmodium yoelii infection. Infect. Immun. 70: 2941-2949.
30. Kobayashi, F., T. Morii, T. Matsui, T. Fujino, Y. Watanabe, W. P. Weidanz, and M. Tsuji. 1996. Production of interleukin 10 during malaria caused by lethal and nonlethal variants of Plasmodium yoelii yoelii. Parasitol. Res. 82: 385-391.
31. Faulkner, L., G. Buchan, and M. Baird. 2000. Interleukin-10 does not affect phagocytosis of particulate antigen by bone marrow-derived dendritic cells but does impair antigen presentation. Immunology 99: 523-531.
32. Corinti, S., C. Albanesi, A. la Sala, S. Pastore, and G. Girolomoni. 2001. Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol. 166: 4312-4318.
33. Good, M. F., and D. L. Doolan. 1999. Immune effector mechanisms in malaria. Curr. Opin. Immunol. 11: 412-419.
34. Morel, P. A., M. Feili-Hariri, P. T. Coates, and A. W. Thomson. 2003. Dendritic cells, T cell tolerance and therapy of adverse immune reactions. Clin. Exp. Immunol. 133: 1-10.
35. + cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. J. Immunol. 149: 966-971.
36. + T lymphocyte response to P. falciparum circumsporozoite protein in naturally-exposed malaria endemic populations in Thailand. Southeast Asian J. Trop. Med. Public Health 30:405-411.
37. Kierszenbaum, F., E. Moretti, and M. B. Sztein. 1993. Molecular basis of Trypanosoma cruzi-induced immunosuppression: altered expression by activated human lymphocytes of molecules which regulate antigen recognition and progression through the cell cycle. Biol. Res. 26: 197-207.
38. Kierszenbaum, F., H. Mejia Lopez, and M. B. Sztein. 1993. Does interleukin-2 restore lymphocyte responses suppressed by Trypanosoma cruzi? Immunology 80: 445-450.
39. Sakaida, H., T. Murakami, S. Kawamata, T. Hattori, and T. Uchiyama. 1997. V3 loop of human immunodeficiency virus type 1 suppresses interleukin 2-induced T cell growth. AIDS Res. Hum. Retroviruses 13: 151-159.
40. 2 arrest in human T cells. J. Immunol. 162: 4773-4780.
41. Martini, F., M. G. Paglia, C. Montesano, P. J. Enders, M. Gentile, C. D. Pauza, C. Gioia, V. Colizzi, P. Narciso, L. P. Pucillo, and F. Poccia. 2003. Vγ9Vδ2 T-cell anergy and complementarity-determining region 3-specific depletion during paroxysm of nonendemic malaria infection. Infect. Immun. 71: 2945-2949.
42. Poccia, F., M. Malkovsky, M. L. Gougeon, M. Bonneville, M. Lopez-Botet, J. J. Fournie, and V. Colizzi. 1997. γδ cell activation or anergy during infections: the role of nonpeptidic TCR ligands and HLA class I molecules. J. Leukocyte Biol. 62: 287-291.
43. Doolan, D. L., C. Khamboonruang, H. P. Beck, R. A. Houghten, and M. F. Good. 1993. Cytotoxic T lymphocyte (CTL) low-responsiveness to the Plasmodium falciparum circumsporozoite protein in naturally-exposed endemic populations: analysis of human CTL response to most known variants. Int. Immunol. 5: 37-46.
44. Kronin, V., K. Winkel, G. Suss, A. Kelso, W. Heath, J. Kirberg, H. von Boehmer, and K. Shortman. 1996. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their 1L-2 production. J. Immunol. 157: 3819-3827.
45. + T-cell responses. Immunol. Cell Biol. 83: 307-312.